UnitedHealth Group (UNH) has staged a remarkable recovery, climbing approximately 78% from its 2023 low to trade near $420. The stock has formed a golden cross pattern, with the 50-day moving average crossing above the 200-day moving average, a signal that often precedes further gains. Investors are now asking whether the rally has more room to run.
Policy Tailwinds Drive Rebound
The turnaround began after the Trump administration announced a 2.48% increase in Medicare Advantage payments for 2025, amounting to $13 billion. This was significantly higher than the 0.09% initially proposed by the Centers for Medicare & Medicaid Services (CMS). A Morningstar analyst noted that final rates typically exceed initial proposals, and investors welcomed the continuation of this pattern despite ongoing regulatory scrutiny.
The policy shift has lifted the entire health insurance sector. CVS Health, which also operates a large insurance business, has rebounded sharply from its 2023 low of $43.55 to trade above $103. Humana has surged 135% from its low. UnitedHealth, as the largest U.S. health insurer, has been a primary beneficiary.
Strong Earnings and Raised Guidance
UnitedHealth's first-quarter results exceeded expectations. Revenue reached $111.72 billion, above the consensus estimate of $109.57 billion, reflecting sustained demand. Earnings per share came in at $7.23, beating the $6.57 forecast. The company raised its full-year adjusted earnings guidance to $18.25 per share and expects annual revenue of $439 billion. Analysts project revenue could exceed $444 billion.
Several Wall Street firms have upgraded their price targets. Bank of America raised its target to $475 from $450, while Leerink Partners and Mizuho remain bullish. The positive sentiment is supported by the company's strong market position and the favorable regulatory environment.
Technical Outlook Points Higher
From a technical perspective, UNH has broken above key resistance at $381, the October 2023 high, which also served as the neckline of a double-bottom pattern. The stock is trading above the Ichimoku cloud, indicating bullish momentum. The golden cross adds to the constructive outlook. The next major target is $500, representing roughly 19% upside from current levels.
However, risks remain. The stock's rapid ascent may lead to short-term pullbacks, and any adverse policy changes or earnings disappointments could reverse gains. Investors should monitor upcoming quarterly reports and regulatory developments.
For context, UnitedHealth's rally has been a key driver of the Dow Jones Industrial Average's recent record highs. As noted in our coverage of the Dow Jones hitting 52,905, UnitedHealth was among the leaders. The company's performance also contrasts with other sectors; for instance, Ethereum's bounce from $1,700 has been capped by tepid demand, highlighting the divergence between equities and crypto markets.
In summary, UnitedHealth Group's fundamentals and technicals support further upside, but investors should remain vigilant given the stock's extended rally and external risks.
This article is for informational purposes only and does not constitute financial advice.
